Multicenter Phase II Study of IMC-A12 in Patients With Thymoma and Thymic Carcinoma Who Have Been Previously Treated With Chemotherapy

Clinical Trial ID NCT00965250

Rank	Title	Journal	Year	PubWeight™‹?›
1	The World Health Organization histologic classification system reflects the oncologic behavior of thymoma: a clinical study of 273 patients.	Cancer	2002	3.29
2	Small is beautiful: insulin-like growth factors and their role in growth, development, and cancer.	J Clin Oncol	2010	1.68
3	Cixutumumab for patients with recurrent or refractory advanced thymic epithelial tumours: a multicentre, open-label, phase 2 trial.	Lancet Oncol	2014	1.40
4	Thymic malignancies: from clinical management to targeted therapies.	J Clin Oncol	2011	1.25
5	Treatment of malignant thymoma.	Curr Opin Oncol	2005	0.95
6	18F-fluorodeoxyglucose positron emission tomography in the management of patients with thymic epithelial tumors.	Clin Cancer Res	2013	0.84
7	Systemic treatment of malignant thymoma: a decade experience at a single institution.	Am J Clin Oncol	2006	0.83
8	Modulation of insulin-like growth factor-1 receptor and its signaling network for the treatment of cancer: current status and future perspectives.	Oncol Rev	2013	0.79